Seres Therapeutics is a clinical-stage biotherapeutic company that researches and develops ecobiotic therapeutic products.
Read moreAnnual Revenue
$140.7M
Seres Therapeutics's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 241.5M. Over the last four quarters, Seres Therapeutics's revenue has decreased by 71.6%. Specifically, in Q1 2022's revenue was $1.5M; in Q4 2021, it was $7.2M; in Q3 2021, it was $126.7M; in Q2 2021, Seres Therapeutics's revenue was $5.3M.